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Background  
 
Mitochondrial DNA (mtDNA) mutation disorders are a group of diseases that are transmitted 
exclusively through the maternal line. Most pathogenic mtDNA mutations are present in a 
heteroplasmic form containing both wild type and mutated mtDNA. In the absence of 
potential cure, pre-implantation genetic diagnosis (PGD) is expected to diagnose the level of 
heteroplasmy and prevent transmission of such disorders. The aim of this study was to test the 
reliability of PGD in a heteroplasmic mouse model containing mtDNA genotypes from BALB 
and NZB mice.  
 
Observations  
 
First polar bodies (PB) were biopsied from metaphase II (MII) oocytes, which were fertilized 
by intra-cytoplasmic sperm injection to analyse second PB and zygotes. Zygotes were further 
cultured to harvest blastomeres from 2, 4 and 8-cell embryos. Heteroplasmic load was 
measured by restriction fragment length polymorphism method in 162 samples. Results were 
analysed by Wilcoxon Signed Rank test (significant at p<0.05) and Pearson’s correlation test 
(r). No significant difference was seen in levels of heteroplasmy between the first PB (n=10) 
and ooplasm of MII oocytes (n=10) (r=0.92); between first PB (n=10), second PB (n=10) and 
zygotes (n=10) (r=0.91 and 0.92 respectively); between first and second PBs (r=0.82); 
between first PB (n=19), second PB (n=19) and blastomeres (n=74) (r=0.89 and 0.90 
respectively); and also among blastomeres (r=0.96). The difference in heteroplasmic load 
ranged from 0.09 to 15% between MII oocytes and first PBs; 0.34 to 20.85% between first 
and second PBs; 0.16 to 8.81% between zygotes and first PBs; 0.29 to 8.82% between zygotes 
and second PBs, 0.03 to 15.17% between first PB and blastomeres; and 0.06 to 16.35% 
between second PB and blastomeres. The inter-blastomere variation ranged from 0.00 to 
12.10%.   
 
Conclusions  
 
Blastomeres are more reliable predictors of heteroplasmic load than the first and/or second 
PBs. Therefore, blastomere biopsy can be an option for PGD. However, intra-blastomere 
variation necessitates the biopsy of two blastomeres for accurate diagnosis, which may 
hamper further embryonic development.   
 
